ArticleNucleic acids research2026
ProteinNetworkSight: a user-friendly platform for transforming co-expression patterns into actionable therapeutic insights through interactive network visualization.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
ProteinNetworkSight (https://proteinnetworksight.jce.ac) addresses a pervasive bottleneck in modern systems biology: the inability to simultaneously analyze multiple feature vectors generated by quantitative techniques-such as machine learning, deep learning, or statistical modeling-that provide series of patterns in a dataset. Modern computational pipelines, ranging from PCA to deep autoencoders, rarely identify a single gene list; instead, they extract a series of distinct patterns representing diverse patient subgroups or independent components. Current web servers are ill-equipped for this high-dimensional reality, forcing researchers to analyze vectors one-by-one or merge them into a static consensus, obliterating unique topological signatures. ProteinNetworkSight introduces a novel web server architecture for simultaneous multi-pattern analysis. Unlike standard tools, our server accepts multi-column tables and transforms every input vector into a discrete, interactive protein-protein interaction network in a single run. This batch vector architecture allows side-by-side visualization of distinct topologies, preserving disease heterogeneity. Furthermore, the server enables prescriptive intervention by calculating a composite perturbation score to identify key protein nodes specific to each pattern. By mapping FDA-approved anti-cancer drugs to these targets, it facilitates the rapid design of personalized combinatorial therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.